Survanta
Active substance: beractant
SUSPENSION · BERACTANT 25 mg/mL
United StatesActive
Marketing holder: AbbVie Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BERACTANT · 25 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-f99d-7c34-baa4-5e18af6f60c9;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0074-1040
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ENDOTRACHEAL
Sources
- product · openFDA NDC · 0074-1040 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0074-1040 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0074-1040 · Verified 2026-10-09 · open in source